BioSpace News Archive

IBA signs contract to install proton therapy center in Kansas, USA

Construction to host IBA’s Proteus®ONE system expected to start later this year

July 9, 2019
·
4 min read
Addex-Led Consortium Receives €4.85 Million Eurostars Grant to Develop Novel Allosteric Modulator to Treat Post-Traumatic Stress Disorder (PTSD)

Addex Therapeutics announced that it will lead a consortium for the development of small-molecule negative allosteric modulators targeting the metabotropic glutamate receptor 7 as a potential treatment to reduce fear memory in post-traumatic stress disorder.

July 9, 2019
·
4 min read
Luxembourg in a European consortium on diabetic cardiomyopathy

The Luxembourg Institute of Health and IBBL join forces with 20 European partners as part of CARDIATEAM, an Innovative Medicines Initiative translational research project aiming to improve diagnosis and care of diabetic cardiomyopathy, a heart dysfunction caused by diabetes.

July 9, 2019
·
5 min read
Drug Development

CarThera receives FDA approval for Phase 1/2a trial in glioblastoma

SonoCloud ultrasound device for glioblastoma patients will be tested for first time at US clinical sites

July 9, 2019
·
4 min read
Drug Development

Cara Therapeutics Announces Initiation of Phase 2 Trial of Oral KORSUVA™ (CR845/difelikefalin) for Pruritus in Patients with Atopic Dermatitis

Cara Therapeutics, Inc. announced the initiation of a Phase 2 trial of Oral KORSUVA for the treatment of pruritus in patients with atopic dermatitis.

July 9, 2019
·
4 min read
Summit’s DDS-04 Enterobacteriaceae Programme Demonstrates In Vivo Efficacy in Sepsis and Pneumonia

Summit Therapeutics plc announces that it has demonstrated the potential of its DDS-04 series of new class antibiotics as an Enterobacteriaceae-targeted treatment through in vivo proof of concept data in sepsis and pneumonia animal models.

July 9, 2019
·
6 min read
Policy

Aclaris Therapeutics Announces Issuance of Additional Orange Book Listable Patent Covering RHOFADE® (Oxymetazoline Hydrochloride) Cream, 1%

Issuance of U.S. Patent No. 10,335,391 Further Strengthens Aclaris’ RHOFADE Patent Portfolio

July 9, 2019
·
5 min read
BioMidwest

WindMIL Therapeutics and University of Michigan Announce Collaboration to Collect Bone Marrow from Patients with Head and Neck Cancer to Develop Marrow Infiltrating Lymphocytes (MILs™)

WindMIL Therapeutics and the University of Michigan Rogel Cancer Center today announced that the first patients have been identified in an investigator-sponsored study for the collection of bone marrow from patients with head and neck squamous cell carcinoma.

July 9, 2019
·
3 min read
Business

CytomX Therapeutics Announces Second Target Selection and Program Initiation with AbbVie Under Ongoing, Multi-Program Strategic Oncology Collaboration

CytomX Therapeutics, Inc. announced the second target selection by its partner AbbVie under the companies’ 2016 Discovery Collaboration and Licensing Agreement to discover and develop Probody drug conjugates.

July 9, 2019
·
5 min read
Pharm Country

Cognition Therapeutics Receives $3.3 Million NIA Grant to Conduct qEEG Study of Elayta™ with World-Leading Alzheimer’s Biomarker Experts

Investigating Quantitative EEG as Biomarker of Patient Response to Treatment in Future Efficacy Studies

July 9, 2019
·
4 min read